Cargando…
Very high-risk prostate cancer: multimodality treatment will be the new frontier
Autores principales: | Campobasso, Davide, Prati, Giuseppe, Frattini, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Urological Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656377/ https://www.ncbi.nlm.nih.gov/pubmed/29104799 http://dx.doi.org/10.5173/ceju.2017.1535 |
Ejemplares similares
-
Multimodality treatment in hormone-refractory prostate cancer patients with bone metastases
por: Lam, Marnix G. E. H., et al.
Publicado: (2008) -
Synchronous bilateral testis cancer: clinical and oncological management
por: Campobasso, Davide, et al.
Publicado: (2017) -
Preoxygenation in super morbid obese in emergency laparotomy: A new frontier?
por: Mukherjee, Prosenjit, et al.
Publicado: (2023) -
Subcostal artery bleeding after endoscopic combined intrarenal surgery: Signs and treatment
por: Campobasso, Davide, et al.
Publicado: (2022) -
Very-high-risk (VHR) localized prostate cancer: an indication for multimodal therapy
por: Sundi, Debasish, et al.
Publicado: (2019)